- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gennex Laboratories Ltd manufactures Bulk Drugs and IntermediariesBusiness Overview: GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants, Muscle Relaxants, Analgesic and Anti Fungal, etc.
Gennex Laboratories has set a book closure period for its 41st Annual General Meeting, which is scheduled for September 30, 2026. The company's Register of Members and Share Transfer Books will be closed from September 23 to September 30, 2026, inclusive. This action is crucial for identifying shareholders eligible to...
Gennex Laboratories has published its financial results for the quarter. Standalone figures show a total income from operations of 36.67 Cr and a net profit of 3.06 Cr. On a consolidated basis, the company reported a total income of 41.85 Cr and a net profit of 4.67 Cr. These key...